Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-09

Clinical Trial Update: D-serine Adjuvant Treatment for Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating D-serine as an adjuvant treatment for Parkinson's disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-serine (D-serine)

Snippet

Sponsor: Herzog Hospital | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED